Emilio Ramazzina

Rovigo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis.

Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 30, 2017

Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia.

Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: February 28, 2017

Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.

Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.

Journal: Advances in therapy

Published: February 02, 2017

Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population.

Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 24, 2016

Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial.

Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial.

Journal: Journal of biological regulators and homeostatic agents

Published: September 23, 2016

Effects of the Antihypertensive Fixed-Dose Combinations on an Early Marker of Hypertensive Cardiac Damage in Subjects at Low Cardiovascular Risk.

Effects of the Antihypertensive Fixed-Dose Combinations on an Early Marker of Hypertensive Cardiac Damage in Subjects at Low Cardiovascular Risk.

Journal: American journal of hypertension

Published: January 08, 2016

Mood Disorders in Uncontrolled Hypertension Despite Multiple Anti-Hypertensive Medications: Searching for a Link.

Mood Disorders in Uncontrolled Hypertension Despite Multiple Anti-Hypertensive Medications: Searching for a Link.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Published: July 06, 2015

Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.

Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk.

Journal: Advances in therapy

Published: June 12, 2015

The ROVIGO study (risk of vascular complications: impact of genetics in old people): protocol, study design, and preliminary results of the initial survey : cardiovascular epidemiology in the elderly.

The ROVIGO study (risk of vascular complications: impact of genetics in old people): protocol, study design, and preliminary results of the initial survey : cardiovascular epidemiology in the elderly.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Published: June 17, 2014

Ultrasound in obstructive lung diseases: the effect of airway obstruction on diaphragm kinetics. A short pictorial essay.

Ultrasound in obstructive lung diseases: the effect of airway obstruction on diaphragm kinetics. A short pictorial essay.

Journal: Journal of ultrasound

Published: May 05, 2014

B-lines: to count or not to count?

B-lines: to count or not to count?

Journal: JACC. Cardiovascular imaging

Published: November 11, 2013

Aliskiren improves blood pressure control and prevents cardiac damage in high-risk hypertensive subjects.

Aliskiren improves blood pressure control and prevents cardiac damage in high-risk hypertensive subjects.

Journal: Minerva cardioangiologica

Published: July 13, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026